Laura a. strom, md - curriculum vitae

UNIVERSITY OF COLORADO - SCHOOL OF MEDICINE

CURRICULUM
LAURA A. STROM


Office Address:
EDUCATION/TRAINING
M.D. The Pennsylvania State University, College of Medicine 2004-present Clinical Science Research Certificate
POST GRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS
Internship, (Psychiatry) Pennsylvania State University, College of Medicine Internship, (Medicine) University of CO, Health Sciences Center Resident, (Neurology) University of CO, Health Sciences Center Post doctoral fellowship (Epilepsy) University of CO, Health Sciences Center
FACULTY APPOINTMENTS
2005-present Assistant Professor of Neurology, University of CO, Health Sciences Center
CURRENT LICENSURE
State of Colorado # 40393

MEDICAL BOARD CERTIFICATION
American Board of Psychiatry and Neurology, 2007

AWARDS AND HONORS

1992

MEMBERSHIPS IN PROFESSIONAL AND SCIENTIFIC SOCIETIES
American Academy of Neurology
American Clinical Neurophysiology Society
American Epilepsy Society
CURRENT COMMITTEES / COMMUNITY SERVICE
Physicians Advisory Board – Epilepsy Foundation of Colorado

CURRENT RESEARCH SUPPORT

Protocol # 08 -0188 An Open Label Extension Study to Evaluate the Safety, Tolerability and Efficacy
of Ganaxolone as an Add-on Therapy in Adult Subjects with Epilepsy Consisting of Uncontrolled
Partial-onset Seizures. A multi-centered trial (Principal Investigator) Marinus Pharmaceuticals, Inc.
Closing November 2009
Supernus Prosper 301 study: Multicenter, Double-Blind, Randomized, Placebo-Controlled, Three-
Arm, Parallel Group Study to Evaluate the Efficacy and Safety of Oxcarbazepine Extended-Release
(OXC XR) (1200 and 2400mg/day) as Adjunctive Therapy in Subjects with Refractory Partial
Seizures due to Epilepsy on up to Three Concomitant Antiepileptic Medications
Supernus Prosper 302 study: Multicenter, Open-Label Extension Study to Evaluate the Long-Term
Safety and Tolerability of Oxcarbazepine Extended-Release (OXC XR) as Adjunctive Therapy in
Subjects with Refractory Partial Epilepsy on up to Two Concomitant Antiepileptic Medications
Sepracor INC Research 093-045 study: Double-Blind, Randomized, Historical Control Study of
the Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects with Partial
Epilepsy Not Well Controlled by Current Antiepileptic Drugs

PUBLICATIONS/CHAPTERS

1. Strom, L.A., J.R. Anderson, J.R. Gandler. Journal of Chemical Education 69 (7): 588. The
Synthesis of E-Beta-bromostyrene – an experiment illustrating the use of IR bending modes to distinguish E-isomers and Z-isomers and the concept of kinetic and thermodynamic controlled reactions. 2. Spitz MC, Strom LA, Fisch B. Principles and Practice of Electrophysiological and Video
Monitoring in Epilepsy and Intensive Care. Chap. 12 Diagnostic and Localizing Extracranial EEG Features of Epileptic Seizures. (Bruce Fisch, MD, editor) Demos Medical Publishing. 3. Lauren Frey, Laura A. Strom, Archana Shrestha, Mark Spitz. End of dose emergent
psychopathology in ambulatory epilepsy patients taking stable-dose lamotrigine monotherapy: A case series of six patients. Epub ahead of manuscript Epilepsy & Behavior, May 16, 2009.

Source: http://www.cusomgateway.com/uploaded-provider-files/3073/Stro2009.pdf